4//SEC Filing
MOLL FREDERIC H 4
Accession 0001642545-24-000055
CIK 0001642545other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:15 PM ET
Size
18.1 KB
Accession
0001642545-24-000055
Insider Transaction Report
Form 4
MOLL FREDERIC H
Director
Transactions
- Sale
Common Stock
2024-02-21$259.91/sh−5,528$1,436,782→ 293,611 total - Sale
Common Stock
2024-02-21$255.95/sh−16,464$4,213,961→ 324,613 total - Sale
Common Stock
2024-02-21$258.09/sh−8,649$2,232,220→ 301,799 total - Sale
Common Stock
2024-02-21$261.96/sh−1,200$314,352→ 287,521 total - Sale
Common Stock
2024-02-21$255.14/sh−6,444$1,644,122→ 341,077 total - Sale
Common Stock
2024-02-21$256.82/sh−14,165$3,637,855→ 310,448 total - Sale
Common Stock
2024-02-21$258.95/sh−2,660$688,807→ 299,139 total - Sale
Common Stock
2024-02-21$260.80/sh−4,890$1,275,312→ 288,721 total
Footnotes (8)
- [F1]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $254.43 to $255.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $255.43 to $256.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $256.43 to $257.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $257.43 to $258.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $258.43 to $259.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F6]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $259.44 to $260.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F7]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $260.45 to $261.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F8]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $261.54 to $262.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Documents
Issuer
Shockwave Medical, Inc.
CIK 0001642545
Entity typeother
Related Parties
1- filerCIK 0001260157
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 8:15 PM ET
- Size
- 18.1 KB